Switch to
More onapp

Jenburkt Pharmaceuticals Ltd

JENBURPH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹264 cr, stock is ranked 1,648
Moderate RiskStock is 2.04x as volatile as Nifty
591.7515.20 (+2.64%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹264 cr, stock is ranked 1,648
Moderate RiskStock is 2.04x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
11.87
PB RatioPB Ratio
2.25
Dividend YieldDiv. Yield
2.08%
Sector PESector PE
35.69
Sector PBSector PB
4.33
Sector Div YldSctr Div Yld
0.89%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jenburkt Pharmaceuticals Limited is an India-based company that is engaged in the business of manufacturing, producing, developing and marketing a range of branded pharmaceuticals and health care products. The Company offers pharmaceutical products for various therapeutic areas, analgesic and antipyretics anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer division, cough and cold, muscle relaxants neuropathic pain, nutraceuticals and pain management. The Company's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets and others. The Company's manufacturing plant is located in Sihor-Gujarat. The Company's products are exported to approximately 13 countries globally.

Financial TrendFinancial statements 

2019202020212022126.05123.11113.60128.9319.7914.8716.5122.29
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Cash Dividend 
Ex. DateJul 21, 2022

Final • Div/Share: ₹ 12

Cash Dividend 
Ex. DateAug 30, 2021

Final • Div/Share: ₹ 10.2

Cash Dividend 
Ex. DateMar 18, 2020

Interim • Div/Share: ₹ 8.1

See all events